Skip to content
☰ Menu
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Rapid Reversal of Suicidal Depression: Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD)

Authors not listed

Brigham and Women's Hospital · 2023

Dysbiosis Human Randomized controlled trial
＋ Sign in to save

Abstract

This study is a randomized open-label single-blind non-inferiority comparative effectiveness study of ECT vs. KET for the treatment of Acute Suicidal Depression (ASD).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-13 MST

Cite this

APA
Anonymous. (2023). Rapid Reversal of Suicidal Depression: Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD). <em>Brigham and Women's Hospital</em>. https://clinicaltrials.gov/study/NCT06034821
Vancouver
Anonymous. Rapid Reversal of Suicidal Depression: Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD). Brigham and Women's Hospital. 2023.
BibTeX
@misc{anon2023RapidR, title = {Rapid Reversal of Suicidal Depression: Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD)}, author = {Anonymous}, journal = {Brigham and Women's Hospital}, year = {2023}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings